Hikma Pharmaceuticals PLC (HIK.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.6B |
| Enterprise Value | 5.88B |
| P/E Ratio | 12.47 |
| PEG Ratio | -0.13 |
| Price/Sales Ratio | 1.37 |
| Price/Book Ratio | 1.86 |
| Enterprise/Revenue | 1.87 |
| Enterprise/EBITDA | 7.16 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.19 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.15 |
Income Statement
| Revenue | 3.35B |
| Revenue/Share | 16.12 |
| Gross Profit | 1.44B |
| EBITDA | 845M |
| Net Income | 410.43M |
| Diluted EPS | 1.84 |
Balance Sheet
| Total Cash | 290.5M |
| Total Cash/Share | 1.37 |
| Total Debt | 1.97B |
| Total Debt/Equity | 0.78 |
| Current Ratio | 1.98 |
| Book Value Per Share | 12.05 |
Price History
| 52-Week Change | -10.89 |
| 52-Week High | 1,865 |
| 52-Week Low | 1,187 |
| Moving Average 50 Days | 1,568.94 |
| Moving Average 200 Days | 1,484.45 |
Statistics
| Average Volume | 1.06M |
| Shares Outstanding | 208.95M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.74 |
| Trailing Annual Dividend Yield | 3.32 |
| Payout Ratio | 0.47 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
